LXR inhibitor, GSK-2033, Purity ≥98%

Synonym: 1221277-90-2; GSK2033; GSK 2033; 2,4,6-Trimethyl-N-[[4-(3-methylsulfonylphenyl)phenyl]methyl]-N-[[5-(trifluoromethyl)furan-2-yl]methyl]benzenesulfonamide; LXR inhibitor

CAS Number: 1221277-90-2
Compound CID: 46203250

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

GSK-2033 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting LXR. The molecular weight of the compound is 591.66, and its molecular formula is C₂₉H₂₈F₃NO₅S₂.

Molecular Weight

591.66

Molecular Formula

C₂₉H₂₈F₃NO₅S₂

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Confirmed by NMR/HPLC/MS.

Applications

GSK-2033 can be used for its potential in stabilizing neuronal activity and reducing inflammation associated with conditions like Alzheimer’s disease.